Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 8/20 | 1.00 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.57 |
| ▸ | GLA | P06280 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.55 |
| ▸ | CYP4Z1 | Q86W10 | 5/20 | 0.55 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.53 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7549692 | 0.98 | SLC9A1 (1.00) | SLC9A1NPC1MAPTRAB9AHCAR3 | |
| SCHEMBL8664499 | 0.98 | SLC9A1 (1.00) | SLC9A1NPC1MAPTRAB9AHCAR3 | |
| SCHEMBL445452 | 0.98 | SLC9A1 (1.00) | SLC9A1NPC1MAPTRAB9AHCAR3 | |
| SCHEMBL535676 | 0.98 | SLC9A1 (1.00) | SLC9A1NPC1MAPTRAB9AHCAR3 | |
| SCHEMBL8633983 | 0.98 | SLC9A1 (1.00) | SLC9A1NPC1MAPTRAB9AHCAR3 | |
| SCHEMBL8406882 | 0.98 | SLC9A1 (1.00) | SLC9A1NPC1MAPTRAB9AHCAR3 | |
| SCHEMBL461412 | 0.98 | SLC9A1 (1.00) | SLC9A1NPC1MAPTRAB9AHCAR3 | |
| SCHEMBL27617630 | 0.98 | SLC9A1 (1.00) | SLC9A1NPC1MAPTRAB9AHCAR3 | |
| SCHEMBL9637546 | 0.97 | SLC9A1 (0.97) | SLC9A1NPC1MAPTRAB9AHCAR3 | |
| SCHEMBL1834794 | 0.95 | SLC9A1 (1.00) | SLC9A1NPC1MAPTRAB9AHCAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 366 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042976-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | FUJIFILM ELECTRONIC MAT USA INC (US) | 2026-02-12 | — | — | US | claimed |
| EP-4562104-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | Fujifilm Electronic Materials U.S.A., Inc. (US) | 2025-06-04 | — | — | EP | claimed |
| CN-118414401-A | Polishing composition and method of use | 富士胶片电子材料美国有限公司 | 2024-07-30 | — | — | CN | claimed |
| EP-4381022-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | FUJIFILM Electronic Materials U.S.A., Inc. (US) | 2024-06-12 | — | — | EP | claimed |
| CN-114945649-B | Polishing composition and method of use thereof | 富士胶片电子材料美国有限公司 | 2024-05-07 | — | — | CN | claimed |
| WO-2024025797-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2024-02-01 | — | — | WO | claimed |
| US-20240034958-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2024-02-01 | — | — | US | claimed |
| CN-117448090-A | Compositions and methods of use thereof | 富士胶片电子材料美国有限公司 | 2024-01-26 | — | — | CN | claimed |
| EP-4034605-B1 | POLISHING COMPOSITIONS AND METHODS OF USE THEREOF | FUJIFILM ELECTRONIC MAT USA INC (US) | 2024-01-17 | — | — | EP | claimed |
| EP-4045226-B1 | POLISHING COMPOSITIONS AND METHODS OF USE THEREOF | FUJIFILM ELECTRONIC MAT USA INC (US) | 2024-01-03 | — | — | EP | claimed |
| EP-3774680-A1 | CLEANING COMPOSITIONS | FUJIFILM Electronic Materials U.S.A, Inc. (US) | 2021-02-17 | — | — | EP | claimed |
| WO-2020251800-A1 | ETCHING COMPOSITIONS | FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) | 2020-12-17 | — | — | WO | claimed |
| US-9895379-B2 | 17alpha, 21-dihydroxypregnene esters as antiandrogenic agents | CASSIOPEA S.P.A. (IT) | 2018-02-20 | — | — | US | claimed |
| US-9644118-B2 | Method of releasably attaching a semiconductor substrate to a carrier | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-05-09 | — | — | US | claimed |
| US-20160257861-A1 | EPHEMERAL BONDING | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2016-09-08 | — | — | US | claimed |
| US-20160228489-A1 | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND THE TREATMENT OF DEGENERATIVE SKIN DISORDERS ESPECIALLY CAUSED BY IONIZING RADIATIONS | SOLOSALE S.R.L. (IT) | 2016-08-11 | — | — | US | claimed |
| EP-2775874-A1 | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND THE TREATMENT OF DEGENERATIVE SKIN DISORDERS ESPECIALLY CAUSED BY IONIZING RADIATIONS | Solosale S.r.l. (IT) | 2014-09-17 | — | — | EP | claimed |
| WO-2013068964-A1 | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND THE TREATMENT OF DEGENERATIVE SKIN DISORDERS ESPECIALLY CAUSED BY IONIZING RADIATIONS | SOLOSALE S.R.L. (IT) | 2013-05-16 | — | — | WO | claimed |
| US-20040180800-A1 | Cleaning and protecting composition with antioxidant and UV light resistance and method of use | HOMECARE LABS, INC. | 2004-09-16 | — | — | US | claimed |
| EP-0256331-B1 | N1-SUBSTITUTED 1H-BENZOTRIAZOLE-HYDROXYETHYL-SULFONE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THE PREPARATION OF DYES | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-11-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160228489-A1 | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND THE TREATMENT OF DEGENERATIVE SKIN DISORDERS ESPECIALLY CAUSED BY IONIZING RADIATIONS | GSTA2, GSTO1, GSTA1 | SLC9A1 2547/4885NPC1 2849/4885MAPT 1873/4885 |
| US-20260042976-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | ACP1, PLOD1, CA1 | SLC9A1 450/4885NPC1 4623/4885MAPT 3595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.